| Adinazolam |
 |
Adinazolam (also known as Adinazolamum, U 41123, 8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine, U-41123, U-41,123, 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine-1-methanamine, 8-chloro-N-N-dimethyl-6-phenyl-, 8-chloro-1-[(dimethylamino)methyl]-6-phenyl-4h-s-triazolo[4,3-a][1,4]benzodiazepine, ({12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methyl)dimethylamine, ((12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaen-3-yl)methyl)dimethylamine or 1-(8-chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-1-yl)-N,N-dimethylmethanamine) is a substance of the triazolobenzodiazepine class.
Chemistry
Adinazolam is a achiral mixture.
Pharmacology
In the nervous system (N) adinazolam acts
- Australia: Adinazolam is a S4 substance.
- Canada: Adinazolam is a Schedule IV substance.
- Brazil: Adinazolam is a B1 substance.
- Germany: Adinazolam is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Adinazolam is a Class C substance.
- United States: Adinazolam is a Unscheduled (Not FDA approved) substance.
- United Nations: Adinazolam is a Unscheduled substance.